These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23023615)

  • 1. [Pulmonary hypertension].
    Kovacs G; Olschewski H
    Dtsch Med Wochenschr; 2012 Oct; 137(40):2026-8. PubMed ID: 23023615
    [No Abstract]   [Full Text] [Related]  

  • 2. Selexipag (Uptravi) for pulmonary arterial hypertension.
    Med Lett Drugs Ther; 2016 Feb; 58(1488):21-3. PubMed ID: 26859660
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathways in pulmonary arterial hypertension: the future is here.
    Sitbon O; Morrell N
    Eur Respir Rev; 2012 Dec; 21(126):321-7. PubMed ID: 23204120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.
    Burger CD
    Ann Am Thorac Soc; 2015 Jun; 12(6):959. PubMed ID: 26075561
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply: Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.
    Hill NS; Badesch D; Benza RL; D'Eletto TA; Farber HW; Gomberg-Maitland M; Hassoun PM; Preston I
    Ann Am Thorac Soc; 2015 Jun; 12(6):960. PubMed ID: 26075562
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug therapy for pulmonary arterial hypertension: what's on the menu today?
    Mehta S
    Chest; 2003 Dec; 124(6):2045-9. PubMed ID: 14665473
    [No Abstract]   [Full Text] [Related]  

  • 7. Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.
    Hill NS; Badesch D; Benza RL; D'Eletto TA; Farber HW; Gomberg-Maitland M; Hassoun PM; Preston I
    Ann Am Thorac Soc; 2015 Feb; 12(2):269-73. PubMed ID: 25590376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition from treprostinil to selexipag in patients with pulmonary arterial hypertension: Case series.
    Fanous SM; Janmohamed M
    Am J Health Syst Pharm; 2018 Dec; 75(23):1877-1881. PubMed ID: 30301721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Targeted therapy of pulmonary arterial hypertension (PAH)].
    Klose H; Opitz C; Bremer H; Ewert R; Bonderman D; Rosenkranz S; Seeger W; Schmeißer A; Harbaum L; Buerke M; Ghofrani HA; Borst MM; Leuchte HH; Lange TJ; Behr J; Ulrich S; Lang I; Olschewski H; Gall H; Kabitz HJ; Kleber FX; Held M; Hoeper MM; Grünig E
    Dtsch Med Wochenschr; 2014 Dec; 139 Suppl 4():S142-50. PubMed ID: 25489684
    [No Abstract]   [Full Text] [Related]  

  • 10. Macitentan (Opsumit) for pulmonary arterial hypertension.
    Med Lett Drugs Ther; 2014 Feb; 56(1436):15-6. PubMed ID: 24663031
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on pharmacotherapy for pulmonary hypertension.
    Prior DL; Adams H; Williams TJ
    Med J Aust; 2016 Sep; 205(6):271-6. PubMed ID: 27627939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy and new types of agents for pulmonary arterial hypertension.
    O'Callaghan DS; Gaine SP
    Clin Chest Med; 2007 Mar; 28(1):169-85, ix. PubMed ID: 17338934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?
    Cannon JE; Pepke-Zaba J
    Semin Respir Crit Care Med; 2013 Oct; 34(5):620-6. PubMed ID: 24037629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful transition from Treprostinil to Selexipag in patient with severe pulmonary arterial hypertension.
    Furukawa A; Tamura Y; Iwahori H; Goto M; Ohashi N; Okabe T; Kawamura A
    BMC Pulm Med; 2017 Oct; 17(1):135. PubMed ID: 29073911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic pulmonary arterial hypertension.
    Souza R; Jardim C; Humbert M
    Semin Respir Crit Care Med; 2013 Oct; 34(5):560-7. PubMed ID: 24037625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pulmonary arterial hypertension.
    Humbert M; Sitbon O; Simonneau G
    N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
    [No Abstract]   [Full Text] [Related]  

  • 18. Changing perceptions in pulmonary hypertension.
    Gerges C; Lang IM
    Lancet Respir Med; 2014 Jan; 2(1):21-3. PubMed ID: 24461891
    [No Abstract]   [Full Text] [Related]  

  • 19. Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy.
    Hardin EA; Chin KM
    Drug Des Devel Ther; 2016; 10():3747-3754. PubMed ID: 27895464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral treprostinil in the treatment of pulmonary arterial hypertension.
    Feldman J; Habib N; Radosevich J; Dutt M
    Expert Opin Pharmacother; 2017 Oct; 18(15):1661-1667. PubMed ID: 28922964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.